Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more

Addgene

pBABEpuroUThTERT+U3-hTR-500 Citations (4)

Originally described in: Telomerase RNA level limits telomere maintenance in X-linked dyskeratosis congenita.
Wong JM, Collins K Genes Dev. 2006 Oct 15. 20(20):2848-58.
PubMed Journal

Articles Citing pBABEpuroUThTERT+U3-hTR-500

Articles
Extensive Proliferation of Human Cancer Cells with Ever-Shorter Telomeres. Dagg RA, Pickett HA, Neumann AA, Napier CE, Henson JD, Teber ET, Arthur JW, Reynolds CP, Murray J, Haber M, Sobinoff AP, Lau LMS, Reddel RR. Cell Rep. 2017 Jun 20;19(12):2544-2556. doi: 10.1016/j.celrep.2017.05.087. PubMed
Administration of a Nucleoside Analog Promotes Cancer Cell Death in a Telomerase-Dependent Manner. Zeng X, Hernandez-Sanchez W, Xu M, Whited TL, Baus D, Zhang J, Berdis AJ, Taylor DJ. Cell Rep. 2018 Jun 5;23(10):3031-3041. doi: 10.1016/j.celrep.2018.05.020. PubMed
FANCM limits ALT activity by restricting telomeric replication stress induced by deregulated BLM and R-loops. Silva B, Pentz R, Figueira AM, Arora R, Lee YW, Hodson C, Wischnewski H, Deans AJ, Azzalin CM. Nat Commun. 2019 May 28;10(1):2253. doi: 10.1038/s41467-019-10179-z. PubMed
SLX4IP Promotes Telomere Maintenance in Androgen Receptor-Independent Castration-Resistant Prostate Cancer through ALT-like Telomeric PML Localization. Mangosh TL, Awadallah WN, Grabowska MM, Taylor DJ. Mol Cancer Res. 2021 Feb;19(2):301-316. doi: 10.1158/1541-7786.MCR-20-0314. Epub 2020 Nov 13. PubMed

If you have published an article using this material, please email us at [email protected] to have your article added to this page.